93 related articles for article (PubMed ID: 1452247)
1. A study of humoral factors in carcinoma cervix.
Agarwal J; Gupta SC; Singh PA; Bisht D; Keswani NK
Indian J Pathol Microbiol; 1992 Jan; 35(1):5-10. PubMed ID: 1452247
[TBL] [Abstract][Full Text] [Related]
2. A sequential study of humoral factors in ovarian neoplasms.
Gupta SC; Agarwal J; Singh PA; Mehdiratta NK; Keswani NK
Indian J Pathol Microbiol; 1994 Jul; 37(3):319-26. PubMed ID: 7814065
[TBL] [Abstract][Full Text] [Related]
3. Immune reactive proteins in patients irradiated for cervical cancer. One year follow up.
Juranić Z; Vucković-Dekić L; Durbaba M
Neoplasma; 1994; 41(4):225-8. PubMed ID: 7935997
[TBL] [Abstract][Full Text] [Related]
4. Quantification of polyethylene glycol precipitable circulating immune complex from carcinoma of cervix patients.
Das S
Arch Geschwulstforsch; 1987; 57(4):283-6. PubMed ID: 3675140
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes in carcinoma of uterine cervix.
Seth P; Balachandran N; Malaviya AN; Kumar R
Clin Exp Immunol; 1979 Oct; 38(1):77-82. PubMed ID: 527257
[TBL] [Abstract][Full Text] [Related]
6. Humoral immunity in patients with carcinoma of the uterine cervix--effects of radiation therapy.
Juranić Z; Vucković-Dekić L; Durbaba M
Neoplasma; 1993; 40(5):297-300. PubMed ID: 8272158
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin classes, complement factors and circulating immune complexes in chronic sinusitis patients.
Ogunleye AO; Arinola OG
Afr J Med Med Sci; 2001 Dec; 30(4):309-12. PubMed ID: 14510109
[TBL] [Abstract][Full Text] [Related]
8. Immunodiagnosis in bone and joint tuberculosis.
Singh SB; Goel SC
J Indian Med Assoc; 2000 Mar; 98(3):97-9. PubMed ID: 11016160
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of circulating immune complexes and serum immunoglobulins in oral cancer patients--a follow up study.
Parveen S; Taneja N; Bathi RJ; Deka AC
Indian J Dent Res; 2010; 21(1):10-5. PubMed ID: 20427899
[TBL] [Abstract][Full Text] [Related]
10. [Nonspecific immunoreactivity in women with dysplasia and cancer of the uterine cervix].
Tosner J; Havel V; Turková M; Fixa B; Zaydlar K
Cesk Gynekol; 1984 Jun; 49(5):338-43. PubMed ID: 6467397
[No Abstract] [Full Text] [Related]
11. E-rosette forming lymphocytes and serum immunoglobulins in breast cancer patients.
Singh RP; Singh VP; Udupa KN
Mater Med Pol; 1991; 23(3):179-81. PubMed ID: 1842710
[TBL] [Abstract][Full Text] [Related]
12. Cervical smear total IgA in adenomatous polyp, dysplasia and carcinoma of the cervix.
Casamassima A; Marinaccio L
Anticancer Res; 1992; 12(4):1315-8. PubMed ID: 1503427
[TBL] [Abstract][Full Text] [Related]
13. The effects of ageing on the immune response to Schistosoma haematobium and hookworm by measuring circulating immune complexes, C3, IgG, IgA and IgM levels in residents of Omi dam area of Kogi State, Nigeria.
Oyeyinka GO; Awogun IA; Akande TM; Awarun JA; Arinola OG; Salimonu LS
Afr J Med Med Sci; 2003 Sep; 32(3):263-7. PubMed ID: 15030085
[TBL] [Abstract][Full Text] [Related]
14. [Irradiated cases of cervical and breast cancer II. Comparative investigation of the immune status of irradiated cases with stage III cancer of the cervix and operated, non-irradiated cases (author's transl)].
Palencia C; Hernuss P; Gitsch E; Weghaupt K; Wicke L; Kärcher KH; Steffen C
Wien Klin Wochenschr; 1975 Dec; 87(24):809-15. PubMed ID: 1084083
[TBL] [Abstract][Full Text] [Related]
15. Depression of high-affinity rosette formation in dysplasia and carcinoma in situ of the uterine cervix: mediation by serum factors.
Bashford J; Gough IR
Cancer Res; 1983 Aug; 43(8):3959-62. PubMed ID: 6861159
[TBL] [Abstract][Full Text] [Related]
16. Cytochemical and immunologic of women treated for squamous cell carcinoma of the cervix.
Olkowski ZL; McLaren JR; Wilkins SA; Maruszczak AJ; Kirchner AB
AJR Am J Roentgenol; 1977 May; 128(5):839-42. PubMed ID: 404913
[TBL] [Abstract][Full Text] [Related]
17. [Suppression of cellular immunity in patients with carcinoma in situ and microinvasive cancer of the cervix uteri].
Marinova-Mutafchieva LP; Chakalova GB; Goranov IT
Vopr Onkol; 1991; 37(4):454-7. PubMed ID: 1832253
[TBL] [Abstract][Full Text] [Related]
18. Immune reactive proteins in renal cell carcinoma patients treated by IFN alpha alone or in combination with vinblastine.
Juranić Z; Stanojević-Bakić N; Maletić V; Borkovacki R
Neoplasma; 1994; 41(4):229-32. PubMed ID: 7935998
[TBL] [Abstract][Full Text] [Related]
19. Immunological studies in HBV-related chronic liver diseases.
Joshi N; Ayesha Q; Habibullah CM
Indian J Pathol Microbiol; 1990 Oct; 33(4):351-4. PubMed ID: 2132503
[TBL] [Abstract][Full Text] [Related]
20. Soluble immune complexes and immunoglobulin (IgG, IgA and IgM) levels in Nigerians with primary liver cell carcinoma.
Olubuyide IO; Salimonu LS; Adeniran SO
Afr J Med Med Sci; 1993 Dec; 22(4):57-62. PubMed ID: 7839931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
